APO Research

APO RESEARCH · REPORT

Tongmai Oral Liquid

Selected research

Industry Research

Tongmai Oral Liquid Industry Research Report 2026

Market perspective

The global Tongmai Oral Liquid market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Tongmai Oral Liquid is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Tongmai Oral Liquid is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Tongmai Oral Liquid is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Tongmai Oral Liquid include Zhejiang Qianjin Pharmaceutical Co., Ltd., Zhejiang Dade Pharmaceutical Group Co., Ltd., Changchun Overseas Pharmaceutical Group Co., Ltd., Tonghua Jinma Pharmaceutical Group Co., Ltd., Shuzhong Pharmaceutical (Jilin) ​​Co., Ltd., Shijiazhuang Northern Pharmaceutical Group Co., Ltd., Shaanxi Han Tang Pharmaceutical Co., Ltd., Xiamen Lizhuo Pharmaceutical Co., Ltd. and Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Tongmai Oral Liquid market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Tongmai Oral Liquid Market by Company

Zhejiang Qianjin Pharmaceutical Co., Ltd.

Zhejiang Dade Pharmaceutical Group Co., Ltd.

Changchun Overseas Pharmaceutical Group Co., Ltd.

Tonghua Jinma Pharmaceutical Group Co., Ltd.

Shuzhong Pharmaceutical (Jilin) ​​Co., Ltd.

Shijiazhuang Northern Pharmaceutical Group Co., Ltd.

Shaanxi Han Tang Pharmaceutical Co., Ltd.

Xiamen Lizhuo Pharmaceutical Co., Ltd.

Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd.

Jilin Longtai Pharmaceutical Co., Ltd.

Hunan Kelun Pharmaceutical Co., Ltd.

Hunan Kangerjia Pharmaceutical Co., Ltd.

Hunan Butian Pharmaceutical Co., Ltd.

Hubei Newland Pharmaceutical Co., Ltd.

Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.

Heilongjiang Nuojie Pharmaceutical Co., Ltd.

Heilongjiang Sunflower Pharmaceutical Co., Ltd.

Henan Xinsifang Pharmaceutical Co., Ltd.

Henan Fusen Pharmaceutical Co., Ltd.

Hebei Ruisheng Pharmaceutical Co., Ltd.

Sinopharm Group Shantou Jinshi Pharmaceutical Co., Ltd.

Guizhou Yibai Pharmaceutical Co., Ltd.

Gansu Pu'an Pharmaceutical Co., Ltd.

Tongmai Oral Liquid Segment by Type

10 Pcs/Box

Others

Tongmai Oral Liquid Segment by Application

Pharmacy

Clinic

Other

Tongmai Oral Liquid Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tongmai Oral Liquid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tongmai Oral Liquid and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tongmai Oral Liquid.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Tongmai Oral Liquid manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Tongmai Oral Liquid by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Tongmai Oral Liquid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Tongmai Oral Liquid Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Tongmai Oral Liquid Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Tongmai Oral Liquid Sales Market Share by Manufacturers (2021-2026) Table 8. Global Tongmai Oral Liquid Revenue of Manufacturers (2021-2026) Table 9. Global Tongmai Oral Liquid Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Tongmai Oral Liquid Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Tongmai Oral Liquid Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Tongmai Oral Liquid, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Tongmai Oral Liquid, Product Type & Application Table 14. Global Tongmai Oral Liquid Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Tongmai Oral Liquid by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Zhejiang Qianjin Pharmaceutical Co., Ltd. Company Information Table 19. Zhejiang Qianjin Pharmaceutical Co., Ltd. Business Overview Table 20. Zhejiang Qianjin Pharmaceutical Co., Ltd. Tongmai Oral Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Zhejiang Qianjin Pharmaceutical Co., Ltd. Tongmai Oral Liquid Product Portfolio Table 22. Zhejiang Qianjin Pharmaceutical Co., Ltd. Recent Developments Table 23. Zhejiang Dade Pharmaceutical Group Co., Ltd. Company Information Table 24. Zhejiang Dade Pharmaceutical Group Co., Ltd. Business Overview Table 25. Zhejiang Dade Pharmaceutical Group Co., Ltd. Tongmai Oral Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Zhejiang Dade Pharmaceutical Group Co., Ltd. Tongmai Oral Liquid Product Portfolio Table 27. Zhejiang Dade Pharmaceutical Group Co., Ltd. Recent Developments Table 28. Changchun Overseas Pharmaceutical Group Co., Ltd. Company Information Table 29. Changchun Overseas Pharmaceutical Group Co., Ltd. Business Overview Table 30. Changchun Overseas Pharmaceutical Group Co., Ltd. Tongmai Oral Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Changchun Overseas Pharmaceutical Group Co., Ltd. Tongmai Oral Liquid Product Portfolio Table 32. Changchun Overseas Pharmaceutical Group Co., Ltd. Recent Developments Table 33. Tonghua Jinma Pharmaceutical Group Co., Ltd. Company Information Table 34. Tonghua Jinma Pharmaceutical Group Co., Ltd. Business Overview Table 35. Tonghua Jinma Pharmaceutical Group Co., Ltd. Tongmai Oral Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Tonghua Jinma Pharmaceutical Group Co., Ltd. Tongmai Oral Liquid Product Portfolio Table 37. Tonghua Jinma Pharmaceutical Group Co., Ltd. Recent Developments Table 38. Shuzhong Pharmaceutical (Jilin) ​​Co., Ltd. Company Information Table 39. Shuzhong Pharmaceutical (Jilin) ​​Co., Ltd. Business Overview Table 40. Shuzhong Pharmaceutical (Jilin) ​​Co., Ltd. Tongmai Oral Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Shuzhong Pharmaceutical (Jilin) ​​Co., Ltd. Tongmai Oral Liquid Product Portfolio Table 42. Shuzhong Pharmaceutical (Jilin) ​​Co., Ltd. Recent Developments Table 43. Shijiazhuang Northern Pharmaceutical Group Co., Ltd. Company Information Table 44. Shijiazhuang Northern Pharmaceutical Group Co., Ltd. Business Overview Table 45. Shijiazhuang Northern Pharmaceutical Group Co., Ltd. Tongmai Oral Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Shijiazhuang Northern Pharmaceutical Group Co., Ltd. Tongmai Oral Liquid Product Portfolio Table 47. Shijiazhuang Northern Pharmaceutical Group Co., Ltd. Recent Developments Table 48. Shaanxi Han Tang Pharmaceutical Co., Ltd. Company Information Table 49. Shaanxi Han Tang Pharmaceutical Co., Ltd. Business Overview Table 50. Shaanxi Han Tang Pharmaceutical Co., Ltd. Tongmai Oral Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Shaanxi Han Tang Pharmaceutical Co., Ltd. Tongmai Oral Liquid Product Portfolio Table 52. Shaanxi Han Tang Pharmaceutical Co., Ltd. Recent Developments Table 53. Xiamen Lizhuo Pharmaceutical Co., Ltd. Company Information Table 54. Xiamen Lizhuo Pharmaceutical Co., Ltd. Business Overview Table 55. Xiamen Lizhuo Pharmaceutical Co., Ltd. Tongmai Oral Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Xiamen Lizhuo Pharmaceutical Co., Ltd. Tongmai Oral Liquid Product Portfolio Table 57. Xiamen Lizhuo Pharmaceutical Co., Ltd. Recent Developments Table 58. Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Company Information Table 59. Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Business Overview Table 60. Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Tongmai Oral Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Tongmai Oral Liquid Product Portfolio Table 62. Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Recent Developments Table 63. Jilin Longtai Pharmaceutical Co., Ltd. Company Information Table 64. Jilin Longtai Pharmaceutical Co., Ltd. Business Overview Table 65. Jilin Longtai Pharmaceutical Co., Ltd. Tongmai Oral Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Jilin Longtai Pharmaceutical Co., Ltd. Tongmai Oral Liquid Product Portfolio Table 67. Jilin Longtai Pharmaceutical Co., Ltd. Recent Developments Table 68. Hunan Kelun Pharmaceutical Co., Ltd. Company Information Table 69. Hunan Kelun Pharmaceutical Co., Ltd. Business Overview Table 70. Hunan Kelun Pharmaceutical Co., Ltd. Tongmai Oral Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Hunan Kelun Pharmaceutical Co., Ltd. Tongmai Oral Liquid Product Portfolio Table 72. Hunan Kelun Pharmaceutical Co., Ltd. Recent Developments Table 73. Hunan Kangerjia Pharmaceutical Co., Ltd. Company Information Table 74. Hunan Kangerjia Pharmaceutical Co., Ltd. Business Overview Table 75. Hunan Kangerjia Pharmaceutical Co., Ltd. Tongmai Oral Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Hunan Kangerjia Pharmaceutical Co., Ltd. Tongmai Oral Liquid Product Portfolio Table 77. Hunan Kangerjia Pharmaceutical Co., Ltd. Recent Developments Table 78. Hunan Butian Pharmaceutical Co., Ltd. Company Information Table 79. Hunan Butian Pharmaceutical Co., Ltd. Business Overview Table 80. Hunan Butian Pharmaceutical Co., Ltd. Tongmai Oral Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Hunan Butian Pharmaceutical Co., Ltd. Tongmai Oral Liquid Product Portfolio Table 82. Hunan Butian Pharmaceutical Co., Ltd. Recent Developments Table 83. Hubei Newland Pharmaceutical Co., Ltd. Company Information Table 84. Hubei Newland Pharmaceutical Co., Ltd. Business Overview Table 85. Hubei Newland Pharmaceutical Co., Ltd. Tongmai Oral Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Hubei Newland Pharmaceutical Co., Ltd. Tongmai Oral Liquid Product Portfolio Table 87. Hubei Newland Pharmaceutical Co., Ltd. Recent Developments Table 88. Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. Company Information Table 89. Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. Business Overview Table 90. Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. Tongmai Oral Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. Tongmai Oral Liquid Product Portfolio Table 92. Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. Recent Developments Table 93. Heilongjiang Nuojie Pharmaceutical Co., Ltd. Company Information Table 94. Heilongjiang Nuojie Pharmaceutical Co., Ltd. Business Overview Table 95. Heilongjiang Nuojie Pharmaceutical Co., Ltd. Tongmai Oral Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Heilongjiang Nuojie Pharmaceutical Co., Ltd. Tongmai Oral Liquid Product Portfolio Table 97. Heilongjiang Nuojie Pharmaceutical Co., Ltd. Recent Developments Table 98. Heilongjiang Sunflower Pharmaceutical Co., Ltd. Company Information Table 99. Heilongjiang Sunflower Pharmaceutical Co., Ltd. Business Overview Table 100. Heilongjiang Sunflower Pharmaceutical Co., Ltd. Tongmai Oral Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Heilongjiang Sunflower Pharmaceutical Co., Ltd. Tongmai Oral Liquid Product Portfolio Table 102. Heilongjiang Sunflower Pharmaceutical Co., Ltd. Recent Developments Table 103. Henan Xinsifang Pharmaceutical Co., Ltd. Company Information Table 104. Henan Xinsifang Pharmaceutical Co., Ltd. Business Overview Table 105. Henan Xinsifang Pharmaceutical Co., Ltd. Tongmai Oral Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Henan Xinsifang Pharmaceutical Co., Ltd. Tongmai Oral Liquid Product Portfolio Table 107. Henan Xinsifang Pharmaceutical Co., Ltd. Recent Developments Table 108. Henan Fusen Pharmaceutical Co., Ltd. Company Information Table 109. Henan Fusen Pharmaceutical Co., Ltd. Business Overview Table 110. Henan Fusen Pharmaceutical Co., Ltd. Tongmai Oral Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Henan Fusen Pharmaceutical Co., Ltd. Tongmai Oral Liquid Product Portfolio Table 112. Henan Fusen Pharmaceutical Co., Ltd. Recent Developments Table 113. Hebei Ruisheng Pharmaceutical Co., Ltd. Company Information Table 114. Hebei Ruisheng Pharmaceutical Co., Ltd. Business Overview Table 115. Hebei Ruisheng Pharmaceutical Co., Ltd. Tongmai Oral Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Hebei Ruisheng Pharmaceutical Co., Ltd. Tongmai Oral Liquid Product Portfolio Table 117. Hebei Ruisheng Pharmaceutical Co., Ltd. Recent Developments Table 118. Sinopharm Group Shantou Jinshi Pharmaceutical Co., Ltd. Company Information Table 119. Sinopharm Group Shantou Jinshi Pharmaceutical Co., Ltd. Business Overview Table 120. Sinopharm Group Shantou Jinshi Pharmaceutical Co., Ltd. Tongmai Oral Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Sinopharm Group Shantou Jinshi Pharmaceutical Co., Ltd. Tongmai Oral Liquid Product Portfolio Table 122. Sinopharm Group Shantou Jinshi Pharmaceutical Co., Ltd. Recent Developments Table 123. Guizhou Yibai Pharmaceutical Co., Ltd. Company Information Table 124. Guizhou Yibai Pharmaceutical Co., Ltd. Business Overview Table 125. Guizhou Yibai Pharmaceutical Co., Ltd. Tongmai Oral Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Guizhou Yibai Pharmaceutical Co., Ltd. Tongmai Oral Liquid Product Portfolio Table 127. Guizhou Yibai Pharmaceutical Co., Ltd. Recent Developments Table 128. Gansu Pu'an Pharmaceutical Co., Ltd. Company Information Table 129. Gansu Pu'an Pharmaceutical Co., Ltd. Business Overview Table 130. Gansu Pu'an Pharmaceutical Co., Ltd. Tongmai Oral Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Gansu Pu'an Pharmaceutical Co., Ltd. Tongmai Oral Liquid Product Portfolio Table 132. Gansu Pu'an Pharmaceutical Co., Ltd. Recent Developments Table 133. Global Tongmai Oral Liquid Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 134. Global Tongmai Oral Liquid Sales by Region (2021-2026) & (K Units) Table 135. Global Tongmai Oral Liquid Sales Market Share by Region (2021-2026) Table 136. Global Tongmai Oral Liquid Sales by Region (2027-2032) & (K Units) Table 137. Global Tongmai Oral Liquid Sales Market Share by Region (2027-2032) Table 138. Global Tongmai Oral Liquid Revenue by Region (2021-2026) & (US$ Million) Table 139. Global Tongmai Oral Liquid Revenue Market Share by Region (2021-2026) Table 140. Global Tongmai Oral Liquid Revenue by Region (2027-2032) & (US$ Million) Table 141. Global Tongmai Oral Liquid Revenue Market Share by Region (2027-2032) Table 142. North America Tongmai Oral Liquid Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. North America Tongmai Oral Liquid Sales by Country (2021-2026) & (K Units) Table 144. North America Tongmai Oral Liquid Sales by Country (2027-2032) & (K Units) Table 145. North America Tongmai Oral Liquid Revenue by Country (2021-2026) & (US$ Million) Table 146. North America Tongmai Oral Liquid Revenue by Country (2027-2032) & (US$ Million) Table 147. Europe Tongmai Oral Liquid Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. Europe Tongmai Oral Liquid Sales by Country (2021-2026) & (K Units) Table 149. Europe Tongmai Oral Liquid Sales by Country (2027-2032) & (K Units) Table 150. Europe Tongmai Oral Liquid Revenue by Country (2021-2026) & (US$ Million) Table 151. Europe Tongmai Oral Liquid Revenue by Country (2027-2032) & (US$ Million) Table 152. Asia Pacific Tongmai Oral Liquid Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 153. Asia Pacific Tongmai Oral Liquid Sales by Country (2021-2026) & (K Units) Table 154. Asia Pacific Tongmai Oral Liquid Sales by Country (2027-2032) & (K Units) Table 155. Asia Pacific Tongmai Oral Liquid Revenue by Country (2021-2026) & (US$ Million) Table 156. Asia Pacific Tongmai Oral Liquid Revenue by Country (2027-2032) & (US$ Million) Table 157. South America Tongmai Oral Liquid Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 158. South America Tongmai Oral Liquid Sales by Country (2021-2026) & (K Units) Table 159. South America Tongmai Oral Liquid Sales by Country (2027-2032) & (K Units) Table 160. South America Tongmai Oral Liquid Revenue by Country (2021-2026) & (US$ Million) Table 161. South America Tongmai Oral Liquid Revenue by Country (2027-2032) & (US$ Million) Table 162. Middle East and Africa Tongmai Oral Liquid Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 163. Middle East and Africa Tongmai Oral Liquid Sales by Country (2021-2026) & (K Units) Table 164. Middle East and Africa Tongmai Oral Liquid Sales by Country (2027-2032) & (K Units) Table 165. Middle East and Africa Tongmai Oral Liquid Revenue by Country (2021-2026) & (US$ Million) Table 166. Middle East and Africa Tongmai Oral Liquid Revenue by Country (2027-2032) & (US$ Million) Table 167. Global Tongmai Oral Liquid Sales by Type (2021-2026) & (K Units) Table 168. Global Tongmai Oral Liquid Sales by Type (2027-2032) & (K Units) Table 169. Global Tongmai Oral Liquid Sales Market Share by Type (2021-2026) Table 170. Global Tongmai Oral Liquid Sales Market Share by Type (2027-2032) Table 171. Global Tongmai Oral Liquid Revenue by Type (2021-2026) & (US$ Million) Table 172. Global Tongmai Oral Liquid Revenue by Type (2027-2032) & (US$ Million) Table 173. Global Tongmai Oral Liquid Revenue Market Share by Type (2021-2026) Table 174. Global Tongmai Oral Liquid Revenue Market Share by Type (2027-2032) Table 175. Global Tongmai Oral Liquid Price by Type (2021-2026) & (US$/Unit) Table 176. Global Tongmai Oral Liquid Price by Type (2027-2032) & (US$/Unit) Table 177. Global Tongmai Oral Liquid Sales by Application (2021-2026) & (K Units) Table 178. Global Tongmai Oral Liquid Sales by Application (2027-2032) & (K Units) Table 179. Global Tongmai Oral Liquid Sales Market Share by Application (2021-2026) Table 180. Global Tongmai Oral Liquid Sales Market Share by Application (2027-2032) Table 181. Global Tongmai Oral Liquid Revenue by Application (2021-2026) & (US$ Million) Table 182. Global Tongmai Oral Liquid Revenue by Application (2027-2032) & (US$ Million) Table 183. Global Tongmai Oral Liquid Revenue Market Share by Application (2021-2026) Table 184. Global Tongmai Oral Liquid Revenue Market Share by Application (2027-2032) Table 185. Global Tongmai Oral Liquid Price by Application (2021-2026) & (US$/Unit) Table 186. Global Tongmai Oral Liquid Price by Application (2027-2032) & (US$/Unit) Table 187. Key Raw Materials Table 188. Raw Materials Key Suppliers Table 189. Tongmai Oral Liquid Distributors List Table 190. Tongmai Oral Liquid Customers List Table 191. Tongmai Oral Liquid Industry Trends Table 192. Tongmai Oral Liquid Industry Drivers Table 193. Tongmai Oral Liquid Industry Restraints Table 194. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Tongmai Oral Liquid Product Image Figure 5. Global Tongmai Oral Liquid Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Tongmai Oral Liquid Market Size (2021-2032) & (US$ Million) Figure 7. Global Tongmai Oral Liquid Sales (2021-2032) & (K Units) Figure 8. Global Tongmai Oral Liquid Average Price (US$/Unit) & (2021-2032) Figure 9. 10 Pcs/Box Product Image Figure 10. Others Product Image Figure 11. Pharmacy Product Image Figure 12. Clinic Product Image Figure 13. Other Product Image Figure 14. Global Tongmai Oral Liquid Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Tongmai Oral Liquid, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Tongmai Oral Liquid Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Tongmai Oral Liquid Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Tongmai Oral Liquid Sales by Region in 2025 Figure 20. Global Tongmai Oral Liquid Revenue by Region in 2025 Figure 21. North America Tongmai Oral Liquid Market Size by Country in 2025 Figure 22. North America Tongmai Oral Liquid Sales Market Share by Country (2021-2032) Figure 23. North America Tongmai Oral Liquid Revenue Market Share by Country (2021-2032) Figure 24. United States Tongmai Oral Liquid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Tongmai Oral Liquid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Tongmai Oral Liquid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Tongmai Oral Liquid Market Size by Country in 2025 Figure 28. Europe Tongmai Oral Liquid Sales Market Share by Country (2021-2032) Figure 29. Europe Tongmai Oral Liquid Revenue Market Share by Country (2021-2032) Figure 30. Germany Tongmai Oral Liquid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Tongmai Oral Liquid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Tongmai Oral Liquid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Tongmai Oral Liquid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Tongmai Oral Liquid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Tongmai Oral Liquid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Tongmai Oral Liquid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Tongmai Oral Liquid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Tongmai Oral Liquid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Tongmai Oral Liquid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Tongmai Oral Liquid Market Size by Country in 2025 Figure 41. Asia Pacific Tongmai Oral Liquid Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Tongmai Oral Liquid Revenue Market Share by Country (2021-2032) Figure 43. China Tongmai Oral Liquid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Tongmai Oral Liquid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Tongmai Oral Liquid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Tongmai Oral Liquid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Tongmai Oral Liquid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Tongmai Oral Liquid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Tongmai Oral Liquid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Tongmai Oral Liquid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Tongmai Oral Liquid Market Size by Country in 2025 Figure 52. South America Tongmai Oral Liquid Sales Market Share by Country (2021-2032) Figure 53. South America Tongmai Oral Liquid Revenue Market Share by Country (2021-2032) Figure 54. Brazil Tongmai Oral Liquid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Tongmai Oral Liquid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Tongmai Oral Liquid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Tongmai Oral Liquid Market Size by Country in 2025 Figure 58. Middle East and Africa Tongmai Oral Liquid Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Tongmai Oral Liquid Revenue Market Share by Country (2021-2032) Figure 60. Egypt Tongmai Oral Liquid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Tongmai Oral Liquid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Tongmai Oral Liquid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Tongmai Oral Liquid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Tongmai Oral Liquid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Tongmai Oral Liquid Sales Market Share by Type (2021-2032) Figure 66. Global Tongmai Oral Liquid Revenue Market Share by Type (2021-2032) Figure 67. Global Tongmai Oral Liquid Price (US$/Unit) by Type (2021-2032) Figure 68. Global Tongmai Oral Liquid Sales Market Share by Application (2021-2032) Figure 69. Global Tongmai Oral Liquid Revenue Market Share by Application (2021-2032) Figure 70. Global Tongmai Oral Liquid Price (US$/Unit) by Application (2021-2032) Figure 71. Tongmai Oral Liquid Value Chain Figure 72. Tongmai Oral Liquid Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Tongmai Oral Liquid Industry Opportunities and Challenges

Scope & coverage.

Types
  • 10 Pcs/Box
  • Others
Applications
  • Pharmacy
  • Clinic
  • Other
Companies covered
  • Zhejiang Qianjin Pharmaceutical Co., Ltd.
  • Zhejiang Dade Pharmaceutical Group Co., Ltd.
  • Changchun Overseas Pharmaceutical Group Co., Ltd.
  • Tonghua Jinma Pharmaceutical Group Co., Ltd.
  • Shuzhong Pharmaceutical (Jilin) ​​Co., Ltd.
  • Shijiazhuang Northern Pharmaceutical Group Co., Ltd.
  • Shaanxi Han Tang Pharmaceutical Co., Ltd.
  • Xiamen Lizhuo Pharmaceutical Co., Ltd.
  • Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd.
  • Jilin Longtai Pharmaceutical Co., Ltd.
  • Hunan Kelun Pharmaceutical Co., Ltd.
  • Hunan Kangerjia Pharmaceutical Co., Ltd.
  • Hunan Butian Pharmaceutical Co., Ltd.
  • Hubei Newland Pharmaceutical Co., Ltd.
  • Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
  • Heilongjiang Nuojie Pharmaceutical Co., Ltd.
  • Heilongjiang Sunflower Pharmaceutical Co., Ltd.
  • Henan Xinsifang Pharmaceutical Co., Ltd.
  • Henan Fusen Pharmaceutical Co., Ltd.
  • Hebei Ruisheng Pharmaceutical Co., Ltd.
  • Sinopharm Group Shantou Jinshi Pharmaceutical Co., Ltd.
  • Guizhou Yibai Pharmaceutical Co., Ltd.
  • Gansu Pu'an Pharmaceutical Co., Ltd.

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Tongmai Oral Liquid Market Size (2021-2032)
  4. 2.2.2 Global Tongmai Oral Liquid Sales (2021-2032)
  5. 2.2.3 Global Tongmai Oral Liquid Market Average Price (2021-2032)
  6. 2.3 Tongmai Oral Liquid by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 10 Pcs/Box
  9. 2.3.3 Others
  10. 2.4 Tongmai Oral Liquid by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Pharmacy
  13. 2.4.3 Clinic
  14. 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Tongmai Oral Liquid Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Tongmai Oral Liquid Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Tongmai Oral Liquid Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Tongmai Oral Liquid Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Tongmai Oral Liquid Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Tongmai Oral Liquid, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Tongmai Oral Liquid, Product Type & Application
  8. 3.8 Global Manufacturers of Tongmai Oral Liquid, Established Date
  9. 3.9 Global Tongmai Oral Liquid Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Zhejiang Qianjin Pharmaceutical Co., Ltd.
  2. 4.1.1 Zhejiang Qianjin Pharmaceutical Co., Ltd. Company Information
  3. 4.1.2 Zhejiang Qianjin Pharmaceutical Co., Ltd. Business Overview
  4. 4.1.3 Zhejiang Qianjin Pharmaceutical Co., Ltd. Tongmai Oral Liquid Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Zhejiang Qianjin Pharmaceutical Co., Ltd. Tongmai Oral Liquid Product Portfolio
  6. 4.1.5 Zhejiang Qianjin Pharmaceutical Co., Ltd. Recent Developments
  7. 4.2 Zhejiang Dade Pharmaceutical Group Co., Ltd.
  8. 4.2.1 Zhejiang Dade Pharmaceutical Group Co., Ltd. Company Information
  9. 4.2.2 Zhejiang Dade Pharmaceutical Group Co., Ltd. Business Overview
  10. 4.2.3 Zhejiang Dade Pharmaceutical Group Co., Ltd. Tongmai Oral Liquid Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Zhejiang Dade Pharmaceutical Group Co., Ltd. Tongmai Oral Liquid Product Portfolio
  12. 4.2.5 Zhejiang Dade Pharmaceutical Group Co., Ltd. Recent Developments
  13. 4.3 Changchun Overseas Pharmaceutical Group Co., Ltd.
  14. 4.3.1 Changchun Overseas Pharmaceutical Group Co., Ltd. Company Information
  15. 4.3.2 Changchun Overseas Pharmaceutical Group Co., Ltd. Business Overview
  16. 4.3.3 Changchun Overseas Pharmaceutical Group Co., Ltd. Tongmai Oral Liquid Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Changchun Overseas Pharmaceutical Group Co., Ltd. Tongmai Oral Liquid Product Portfolio
  18. 4.3.5 Changchun Overseas Pharmaceutical Group Co., Ltd. Recent Developments
  19. 4.4 Tonghua Jinma Pharmaceutical Group Co., Ltd.
  20. 4.4.1 Tonghua Jinma Pharmaceutical Group Co., Ltd. Company Information
  21. 4.4.2 Tonghua Jinma Pharmaceutical Group Co., Ltd. Business Overview
  22. 4.4.3 Tonghua Jinma Pharmaceutical Group Co., Ltd. Tongmai Oral Liquid Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Tonghua Jinma Pharmaceutical Group Co., Ltd. Tongmai Oral Liquid Product Portfolio
  24. 4.4.5 Tonghua Jinma Pharmaceutical Group Co., Ltd. Recent Developments
  25. 4.5 Shuzhong Pharmaceutical (Jilin) ​​Co., Ltd.
  26. 4.5.1 Shuzhong Pharmaceutical (Jilin) ​​Co., Ltd. Company Information
  27. 4.5.2 Shuzhong Pharmaceutical (Jilin) ​​Co., Ltd. Business Overview
  28. 4.5.3 Shuzhong Pharmaceutical (Jilin) ​​Co., Ltd. Tongmai Oral Liquid Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Shuzhong Pharmaceutical (Jilin) ​​Co., Ltd. Tongmai Oral Liquid Product Portfolio
  30. 4.5.5 Shuzhong Pharmaceutical (Jilin) ​​Co., Ltd. Recent Developments
  31. 4.6 Shijiazhuang Northern Pharmaceutical Group Co., Ltd.
  32. 4.6.1 Shijiazhuang Northern Pharmaceutical Group Co., Ltd. Company Information
  33. 4.6.2 Shijiazhuang Northern Pharmaceutical Group Co., Ltd. Business Overview
  34. 4.6.3 Shijiazhuang Northern Pharmaceutical Group Co., Ltd. Tongmai Oral Liquid Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Shijiazhuang Northern Pharmaceutical Group Co., Ltd. Tongmai Oral Liquid Product Portfolio
  36. 4.6.5 Shijiazhuang Northern Pharmaceutical Group Co., Ltd. Recent Developments
  37. 4.7 Shaanxi Han Tang Pharmaceutical Co., Ltd.
  38. 4.7.1 Shaanxi Han Tang Pharmaceutical Co., Ltd. Company Information
  39. 4.7.2 Shaanxi Han Tang Pharmaceutical Co., Ltd. Business Overview
  40. 4.7.3 Shaanxi Han Tang Pharmaceutical Co., Ltd. Tongmai Oral Liquid Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Shaanxi Han Tang Pharmaceutical Co., Ltd. Tongmai Oral Liquid Product Portfolio
  42. 4.7.5 Shaanxi Han Tang Pharmaceutical Co., Ltd. Recent Developments
  43. 4.8 Xiamen Lizhuo Pharmaceutical Co., Ltd.
  44. 4.8.1 Xiamen Lizhuo Pharmaceutical Co., Ltd. Company Information
  45. 4.8.2 Xiamen Lizhuo Pharmaceutical Co., Ltd. Business Overview
  46. 4.8.3 Xiamen Lizhuo Pharmaceutical Co., Ltd. Tongmai Oral Liquid Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Xiamen Lizhuo Pharmaceutical Co., Ltd. Tongmai Oral Liquid Product Portfolio
  48. 4.8.5 Xiamen Lizhuo Pharmaceutical Co., Ltd. Recent Developments
  49. 4.9 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd.
  50. 4.9.1 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Company Information
  51. 4.9.2 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Business Overview
  52. 4.9.3 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Tongmai Oral Liquid Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Tongmai Oral Liquid Product Portfolio
  54. 4.9.5 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Recent Developments
  55. 4.10 Jilin Longtai Pharmaceutical Co., Ltd.
  56. 4.10.1 Jilin Longtai Pharmaceutical Co., Ltd. Company Information
  57. 4.10.2 Jilin Longtai Pharmaceutical Co., Ltd. Business Overview
  58. 4.10.3 Jilin Longtai Pharmaceutical Co., Ltd. Tongmai Oral Liquid Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Jilin Longtai Pharmaceutical Co., Ltd. Tongmai Oral Liquid Product Portfolio
  60. 4.10.5 Jilin Longtai Pharmaceutical Co., Ltd. Recent Developments
  61. 4.11 Hunan Kelun Pharmaceutical Co., Ltd.
  62. 4.11.1 Hunan Kelun Pharmaceutical Co., Ltd. Company Information
  63. 4.11.2 Hunan Kelun Pharmaceutical Co., Ltd. Business Overview
  64. 4.11.3 Hunan Kelun Pharmaceutical Co., Ltd. Tongmai Oral Liquid Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Hunan Kelun Pharmaceutical Co., Ltd. Tongmai Oral Liquid Product Portfolio
  66. 4.11.5 Hunan Kelun Pharmaceutical Co., Ltd. Recent Developments
  67. 4.12 Hunan Kangerjia Pharmaceutical Co., Ltd.
  68. 4.12.1 Hunan Kangerjia Pharmaceutical Co., Ltd. Company Information
  69. 4.12.2 Hunan Kangerjia Pharmaceutical Co., Ltd. Business Overview
  70. 4.12.3 Hunan Kangerjia Pharmaceutical Co., Ltd. Tongmai Oral Liquid Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Hunan Kangerjia Pharmaceutical Co., Ltd. Tongmai Oral Liquid Product Portfolio
  72. 4.12.5 Hunan Kangerjia Pharmaceutical Co., Ltd. Recent Developments
  73. 4.13 Hunan Butian Pharmaceutical Co., Ltd.
  74. 4.13.1 Hunan Butian Pharmaceutical Co., Ltd. Company Information
  75. 4.13.2 Hunan Butian Pharmaceutical Co., Ltd. Business Overview
  76. 4.13.3 Hunan Butian Pharmaceutical Co., Ltd. Tongmai Oral Liquid Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Hunan Butian Pharmaceutical Co., Ltd. Tongmai Oral Liquid Product Portfolio
  78. 4.13.5 Hunan Butian Pharmaceutical Co., Ltd. Recent Developments
  79. 4.14 Hubei Newland Pharmaceutical Co., Ltd.
  80. 4.14.1 Hubei Newland Pharmaceutical Co., Ltd. Company Information
  81. 4.14.2 Hubei Newland Pharmaceutical Co., Ltd. Business Overview
  82. 4.14.3 Hubei Newland Pharmaceutical Co., Ltd. Tongmai Oral Liquid Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Hubei Newland Pharmaceutical Co., Ltd. Tongmai Oral Liquid Product Portfolio
  84. 4.14.5 Hubei Newland Pharmaceutical Co., Ltd. Recent Developments
  85. 4.15 Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
  86. 4.15.1 Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. Company Information
  87. 4.15.2 Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. Business Overview
  88. 4.15.3 Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. Tongmai Oral Liquid Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. Tongmai Oral Liquid Product Portfolio
  90. 4.15.5 Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. Recent Developments
  91. 4.16 Heilongjiang Nuojie Pharmaceutical Co., Ltd.
  92. 4.16.1 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Company Information
  93. 4.16.2 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Business Overview
  94. 4.16.3 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Tongmai Oral Liquid Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Tongmai Oral Liquid Product Portfolio
  96. 4.16.5 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Recent Developments
  97. 4.17 Heilongjiang Sunflower Pharmaceutical Co., Ltd.
  98. 4.17.1 Heilongjiang Sunflower Pharmaceutical Co., Ltd. Company Information
  99. 4.17.2 Heilongjiang Sunflower Pharmaceutical Co., Ltd. Business Overview
  100. 4.17.3 Heilongjiang Sunflower Pharmaceutical Co., Ltd. Tongmai Oral Liquid Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Heilongjiang Sunflower Pharmaceutical Co., Ltd. Tongmai Oral Liquid Product Portfolio
  102. 4.17.5 Heilongjiang Sunflower Pharmaceutical Co., Ltd. Recent Developments
  103. 4.18 Henan Xinsifang Pharmaceutical Co., Ltd.
  104. 4.18.1 Henan Xinsifang Pharmaceutical Co., Ltd. Company Information
  105. 4.18.2 Henan Xinsifang Pharmaceutical Co., Ltd. Business Overview
  106. 4.18.3 Henan Xinsifang Pharmaceutical Co., Ltd. Tongmai Oral Liquid Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Henan Xinsifang Pharmaceutical Co., Ltd. Tongmai Oral Liquid Product Portfolio
  108. 4.18.5 Henan Xinsifang Pharmaceutical Co., Ltd. Recent Developments
  109. 4.19 Henan Fusen Pharmaceutical Co., Ltd.
  110. 4.19.1 Henan Fusen Pharmaceutical Co., Ltd. Company Information
  111. 4.19.2 Henan Fusen Pharmaceutical Co., Ltd. Business Overview
  112. 4.19.3 Henan Fusen Pharmaceutical Co., Ltd. Tongmai Oral Liquid Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Henan Fusen Pharmaceutical Co., Ltd. Tongmai Oral Liquid Product Portfolio
  114. 4.19.5 Henan Fusen Pharmaceutical Co., Ltd. Recent Developments
  115. 4.20 Hebei Ruisheng Pharmaceutical Co., Ltd.
  116. 4.20.1 Hebei Ruisheng Pharmaceutical Co., Ltd. Company Information
  117. 4.20.2 Hebei Ruisheng Pharmaceutical Co., Ltd. Business Overview
  118. 4.20.3 Hebei Ruisheng Pharmaceutical Co., Ltd. Tongmai Oral Liquid Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Hebei Ruisheng Pharmaceutical Co., Ltd. Tongmai Oral Liquid Product Portfolio
  120. 4.20.5 Hebei Ruisheng Pharmaceutical Co., Ltd. Recent Developments
  121. 4.21 Sinopharm Group Shantou Jinshi Pharmaceutical Co., Ltd.
  122. 4.21.1 Sinopharm Group Shantou Jinshi Pharmaceutical Co., Ltd. Company Information
  123. 4.21.2 Sinopharm Group Shantou Jinshi Pharmaceutical Co., Ltd. Business Overview
  124. 4.21.3 Sinopharm Group Shantou Jinshi Pharmaceutical Co., Ltd. Tongmai Oral Liquid Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Sinopharm Group Shantou Jinshi Pharmaceutical Co., Ltd. Tongmai Oral Liquid Product Portfolio
  126. 4.21.5 Sinopharm Group Shantou Jinshi Pharmaceutical Co., Ltd. Recent Developments
  127. 4.22 Guizhou Yibai Pharmaceutical Co., Ltd.
  128. 4.22.1 Guizhou Yibai Pharmaceutical Co., Ltd. Company Information
  129. 4.22.2 Guizhou Yibai Pharmaceutical Co., Ltd. Business Overview
  130. 4.22.3 Guizhou Yibai Pharmaceutical Co., Ltd. Tongmai Oral Liquid Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 Guizhou Yibai Pharmaceutical Co., Ltd. Tongmai Oral Liquid Product Portfolio
  132. 4.22.5 Guizhou Yibai Pharmaceutical Co., Ltd. Recent Developments
  133. 4.23 Gansu Pu'an Pharmaceutical Co., Ltd.
  134. 4.23.1 Gansu Pu'an Pharmaceutical Co., Ltd. Company Information
  135. 4.23.2 Gansu Pu'an Pharmaceutical Co., Ltd. Business Overview
  136. 4.23.3 Gansu Pu'an Pharmaceutical Co., Ltd. Tongmai Oral Liquid Sales, Revenue and Gross Margin (2021-2026)
  137. 4.23.4 Gansu Pu'an Pharmaceutical Co., Ltd. Tongmai Oral Liquid Product Portfolio
  138. 4.23.5 Gansu Pu'an Pharmaceutical Co., Ltd. Recent Developments
5 Global Tongmai Oral Liquid Market Scenario by Region
  1. 5.1 Global Tongmai Oral Liquid Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Tongmai Oral Liquid Sales by Region: 2021-2032
  3. 5.2.1 Global Tongmai Oral Liquid Sales by Region: 2021-2026
  4. 5.2.2 Global Tongmai Oral Liquid Sales by Region: 2027-2032
  5. 5.3 Global Tongmai Oral Liquid Revenue by Region: 2021-2032
  6. 5.3.1 Global Tongmai Oral Liquid Revenue by Region: 2021-2026
  7. 5.3.2 Global Tongmai Oral Liquid Revenue by Region: 2027-2032
  8. 5.4 North America Tongmai Oral Liquid Market Facts & Figures by Country
  9. 5.4.1 North America Tongmai Oral Liquid Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Tongmai Oral Liquid Sales by Country (2021-2032)
  11. 5.4.3 North America Tongmai Oral Liquid Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Tongmai Oral Liquid Market Facts & Figures by Country
  16. 5.5.1 Europe Tongmai Oral Liquid Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Tongmai Oral Liquid Sales by Country (2021-2032)
  18. 5.5.3 Europe Tongmai Oral Liquid Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Tongmai Oral Liquid Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Tongmai Oral Liquid Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Tongmai Oral Liquid Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Tongmai Oral Liquid Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Tongmai Oral Liquid Market Facts & Figures by Country
  41. 5.7.1 South America Tongmai Oral Liquid Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Tongmai Oral Liquid Sales by Country (2021-2032)
  43. 5.7.3 South America Tongmai Oral Liquid Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Tongmai Oral Liquid Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Tongmai Oral Liquid Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Tongmai Oral Liquid Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Tongmai Oral Liquid Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Tongmai Oral Liquid Sales by Type (2021-2032)
  2. 6.1.1 Global Tongmai Oral Liquid Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Tongmai Oral Liquid Sales Market Share by Type (2021-2032)
  4. 6.2 Global Tongmai Oral Liquid Revenue by Type (2021-2032)
  5. 6.2.1 Global Tongmai Oral Liquid Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Tongmai Oral Liquid Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Tongmai Oral Liquid Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Tongmai Oral Liquid Sales by Application (2021-2032)
  2. 7.1.1 Global Tongmai Oral Liquid Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Tongmai Oral Liquid Sales Market Share by Application (2021-2032)
  4. 7.2 Global Tongmai Oral Liquid Revenue by Application (2021-2032)
  5. 7.2.1 Global Tongmai Oral Liquid Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Tongmai Oral Liquid Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Tongmai Oral Liquid Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Tongmai Oral Liquid Value Chain Analysis
  2. 8.1.1 Tongmai Oral Liquid Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Tongmai Oral Liquid Production Mode & Process
  5. 8.2 Tongmai Oral Liquid Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Tongmai Oral Liquid Distributors
  8. 8.2.3 Tongmai Oral Liquid Customers
9 Global Tongmai Oral Liquid Analyzing Market Dynamics
  1. 9.1 Tongmai Oral Liquid Industry Trends
  2. 9.2 Tongmai Oral Liquid Industry Drivers
  3. 9.3 Tongmai Oral Liquid Industry Opportunities and Challenges
  4. 9.4 Tongmai Oral Liquid Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research